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I. Introduction 
[“HI Acetylated-cu-bungarotoxin has been used to 
determine the numbers, densities and precise location 
of acetylcholine receptor (ACh.R) molecules in normal 
and denervated mammalian muscle [l-4] . Two label- 
ed components specifically binding a-bungarotoxin 
(BuTX) have been solubilized from rat diaphragm 
muscle and shown to have apparent molecular weights 
(by gel filtration in 0.2% Triton X-100) of 550 000 
and 200 000, respectively [4]. Only the former is 
found at the endplates and is thought to contain the 
native AChaR. After denervation, a 20-fold increase 
occurs in a BuTX-binding component with an apparent 
mol. wt. of 550 000, but this is then distributed 
throughout the whole muscle. Unlabeled ACh-R with 
the same mol. wt. has been solubilized from denervat- 
ed mammalian muscle, extensively purified (100-200 
fold) and shown to bind choline@ ligands [4-61. 
A detailed description of the purification and proper- 
ties of the ACh-R from denervated cat leg muscles 
will be described elsewhere [7,8] . A partially purified 
preparation of AChaR from rat denervated diaphragm 
has been reconstituted into artificial lipid membranes 
[9]. Here we show, by the protective effects on the 
binding of BuTX, that cholinergic agonists and antagon- 
ists bind with high affinities to this partially purified 
ACh-R preparation from cat denervated muscles. 
2. Materials and methods 
2.1. Preparation of [ 3 H] triacetylated-&3u TX 
Pure BuTX was purified and acetylated with 
North-Holland Publishing Company - Amsterdam 
[3H]acetic anhydride, as described previously [I]. 
By further purification steps a homogeneous species, 
[“HI triacetylated-cu-BuTX ( [3 H] BuTX) of specific 
activity 4.5 Ci/mmol, was obtained, which displayed 
the same specificity but somewhat lower affinity 
than the native toxin [lo] . 
2.2. Assay of(3H]BuTX-bindingactivity 
Toxin-binding activity was measured at 25°C using 
16 nM [ 3 H] BuTX in 0.2% Triton X-l OO/ 1 O-25 mM 
KHZ P04-Ks HPO4, pH 8, by a method utilizing DEAE. 
cellulose filter discs [8,11,12] . For experiments with 
acetylcholine or carbamylcholine, the receptor prepara- 
tion used was preincubated with 1.5 X lo-’ M DFP 
(0.3 X lo-’ M final cont. in control and test reaction 
mixtures) at 5°C for at least 30 min before addition of 
ligand. The buffered-receptor solutions were always 
incubated for at least 15 min at 5°C with the ligands 
before the reaction was started by adding [ 3 H]BuTX. 
After thorough washing, the filters were dried and 
counted by liquid scintillation at 34% efficiency, in 
a toluene-based medium containing 10% (v/v) Soluene- 
100. 
2.3. Preparation of the AC%. R 
Cat lower-leg muscles were denervated by scission 
of the sciatic nerve under anesthesia, and dissected 
out 4 weeks later. The ACh-R was extracted using 1.5% 
Triton X- 100/50 mM KHZ PO., -Ks HP04, pH 8, gel- 
filtered on Sepharose 6B and concentrated by ultra- 
fdtration [4]. The preparation could be stored at 
-15°C for 4 days without appreciable loss in toxin- 
binding activity. For some ligand-binding experiments, 
an ACh-R preparation purified 11 O-fold by affinity 
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chromatography was used [6-81. Preparations of the 
ACh.R purified by gel fntration and affinity chroma- 
tography bound 8 and 150 nmoles of [3 H] BuTX 
per gram protein, respectively. 
2.4. Chemical sources 
Acetylcholine iodide (ACh), carbamylcholine 
chloride, d-tubocurarine chloride (d-TC), choline 
chloride, hexamethonium bromide, atropine sulfate 
and DFP: Sigma; decamethonium bromide and 
pilocarpine hydrochloride: K and K Labs.; Triton 
X- 100 and Soluene- 100: Packard. 
3. Results 
By means of the DEAE-cellulose filter assay 
method and [ 3 H] BuTX of high specific activity, it 
was possible to measure accurately the effects of various 
ligands on the rate of [ 3 H] BuTX binding to the ACh-R, 
in preparations containing relatively small amounts of 
receptor. The total radioactivity bound to the DEAE- 
cellulose disc was directly proportional to the amount 
of ACh.R present in the reaction mixture over a wide 
range of concentrations [8]. 
Fig. 1 shows the binding of [ 3 H] BuTX to AC&R 
as a function of the concentration of radioactive toxin 
4 
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Fig. 1. Binding of [ 3 H] BuTX to partially purified ACh.R as 
a function of toxin concentration. After 20 mm of incubation 
at 25”C, the bound [“HJBuTX was determined using the DEAE- 
cellulose disc assay. Blank values, determined for each con- 
centration of toxin, have been subtracted. 
2.5=ld*M CCh 
I I , 
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Fig. 2. Binding of [ 3 H] BuTX (16 nM) to partially purified 
ACh.R (3 nM) at 25” alone (o), and in the presence of 
carbamyl-choline (A), ACh (0) and d-TC (0). 
used. The results show that only a single saturable 
site for [3 H] BuTX was detectable. The reaction of 
[“HI BuTX with ACh.R, alone and in the presence of 
carbamylcholine, ACh or d-TC, is illustrated in fig. 2. 
The ACh.R preparation showed high affinity for the 
ligands but the kinetics were complicated by the 
fact that a fraction of the activity (approx. 12% of 
total), which displayed the usual fast reaction rate 
with [3H]BuTX, could not be protected by choliner- 
gic ligands (ACh, carbamylcholine, decamethonium or 
d-TC), even at high concentrations (e.g., 2.5 X lo-’ 
M d-TC; fig. 2). Various types of control (e.g., heat- 
inactivated receptor, omission of the receptor, or 
reaction performed at 5°C for 1 min) tested did not 
yield this anomalous contribution. Hence, the 
ligand-insensitive BuTX-binding component is inac- 
tive in the conditions where the specific (ligand- 
sensitive) component is itself inactive and is not an 
artefact of the assay system. Since this fraction was 
independent of all ligands tested, it was taken to be 
a minor second component and its contribution was 
subtracted in every case. When this was done (fig. 3) 
the reaction is essentially linear for the first 25 min 
at 3-4 nM receptor concentration, so that initial 
rates could be measured with accuracy. Similar com- 
petition experiments were performed with ACh.R, 
purified by gel filtration and affinity chromatography, 
for a total of 5 ligands, and the protection constants 
were estimated (table 1) using the equation [ 131: 
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assume that the toxin can bind only to the free 
ACh.R; Vi is then proportional to the concentration 
of sites which are not occupied by the ligand, and 
KP is equal to the dissociation constant of the ligand- 
ACh.R complex. That this equality holds, has been 
shown in the case of electroplaque ACh.R reacting 
with a cobratoxin, by direct binding measurements 
with several igands [ 141. 
The muscarinic ligands, atropine and pilocarpine, 
when used at concentrations (1 X lo-’ and 5 X 10e6 
M, respectively) that normally block muscarinic-type 
receptors, showed no protection. Likewise, choline 
(2 X lo- ’ M) did not affect the rate of [ 3 H] BuTX 
Fig. 3. Rates of [ 3 H] BuTX binding to ACh.R alone (0) and 
in the presence of hexamethonium (a) and decamethonium 
(01. 
binding to ACh.R. 
4. Discussion 
‘i KP -=- 
V Kp+L 
where v and Vi are the initial rates measured in the 
absence and presence of ligand, respectively; L is 
the concentration of ligand, and K, is the protection 
constant of the ligand. In using this equation we 
The present results show that detergent-solubilized 
ACh.R, partially purified from cat denervated leg 
muscles, binds cholinergic agonists and antagonists 
with high affinities. Similar binding constants were 
obtained (in the cases of ACh, carbamylcholine and 
d-TC) for the ACh.R which had been purified by 
affinity chromatography. The apparent binding 
Table 1 
Apparent protection constants for ACh.R Protein purified from 
cat denervated leg muscles 
Gel-filtered 
ACh.R 
ACh.R purified Electrophorus 
by affinity - 
chromatogra- membrane 
phy ACh.R** 
Agonists 
Acetylcholine 
Carbamylcholine 
Decamethonium 
Antagonists 
d-Tubocurarine 
Hexamethonium 
(Ml (Ml (Ml 
1.7 x 10-6* 1 x 10-6* 1.5 x 10-h 
1.0 x 1o-5* 0.9 x lo-$* 4.0 x 1o-5 
0.5 x 1o-6 0.8 x lo-* 
1.5 x lo-’ 3.3 x lo-’ 1.7 x lo-’ 
3.4 x 1o-4 0.6 x lo-’ 
Apparent protection constants (Kp) were estimated (see text) by follow. 
ing the effect of the ligand on the mitral rate of [ 3 H] BuTX binding to 
partially purified AC%-R at 25°C. 
* In the presence of 0.3 x 10-s M DFP. 
** Values given for comparison: taken from Weber and Changeux [ 141, 
measured by protection against he binding of [ 3 H] a-neurotoxin 
(Naja nigricollis), at 22°C in Ringer’s solution. 
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constants obtained for the antagonists are very similar 
to those obtained for both membrane-bound and 
purified ACh.R of the Electrophoms electroplaque 
[ 14,151. However, the affinities obtained for the 
agonists are similar only to those for membrane-bound 
Electrophom ACkR, since solubilization of the ACh- 
R from membrane fragments of Electrophoms causes 
an increase of 1 O-SO fold in its affinity for agonists 
[ 161. Different affinities for these ligands, and their 
behavior upon solubilization have been reported by 
several aboratories for the AChaR of Torpedo 
electroplax [ 14,17- 191. We, therefore, presume that 
the denervated muscle receptor is similar in binding 
properties to that of Electrophoms, but does not 
show the change to much higher affinity for ligands 
upon release from its state in the membrane. 
It is interesting that only a small proportion of 
(< 15%) of the [3H]BuTX-binding activity of this 
solubilized muscle receptor is insensitive to cholin- 
ergic ligands. For the ACh.R of cultured myoblasts, 
a similar small resistant fraction is apparent in the 
data of Patrick et al. [20]. In contrast, in the intact 
innervated muscle, 50% of the toxin-binding sites at 
the endplates are readily protected by d-TC [ 11. The 
d-TC-insensitive fraction is only 35% in the intact 
denervated mouse diaphragm muscle [21] . As 80% 
of the total BuTX-binding sites are solubilized by 
detergent [4] it is possible that the d-TC-insensitive 
fraction remains insoluble, or is a different compc- 
nent that is not purified with the true ACh-binding 
receptor. The affinity of the muscle receptor for d-TC 
found here is an agreement with that estimated 
pharmacologically by a null-point method: 3.9 X 
10m7 M (at 30°C) for innervated hamster diaphragm 
[22]. Since the denervated muscles show in situ a 
lower apparent affinity for d-TC [21], possibly a 
change in the direction of increased affinity for this 
antagonist occurs upon solubilization. 
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